Your browser doesn't support javascript.
loading
Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion.
Kleinfelter, Lara M; Jangra, Rohit K; Jae, Lucas T; Herbert, Andrew S; Mittler, Eva; Stiles, Katie M; Wirchnianski, Ariel S; Kielian, Margaret; Brummelkamp, Thijn R; Dye, John M; Chandran, Kartik.
Afiliación
  • Kleinfelter LM; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Jangra RK; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Jae LT; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
  • Mittler E; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Stiles KM; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Wirchnianski AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
  • Kielian M; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Brummelkamp TR; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA kartik.chandran@einstein.yu.edu john.m.dye1.civ@mail.mil.
  • Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA kartik.chandran@einstein.yu.edu john.m.dye1.civ@mail.mil.
mBio ; 6(4): e00801, 2015 Jun 30.
Article en En | MEDLINE | ID: mdl-26126854
ABSTRACT
UNLABELLED Hantaviruses cause hemorrhagic fever with renal syndrome (HFRS) in the Old World and a highly fatal hantavirus cardiopulmonary syndrome (HCPS) in the New World. No vaccines or antiviral therapies are currently available to prevent or treat hantavirus disease, and gaps in our understanding of how hantaviruses enter cells challenge the search for therapeutics. We performed a haploid genetic screen in human cells to identify host factors required for entry by Andes virus, a highly virulent New World hantavirus. We found that multiple genes involved in cholesterol sensing, regulation, and biosynthesis, including key components of the sterol response element-binding protein (SREBP) pathway, are critical for Andes virus entry. Genetic or pharmacological disruption of the membrane-bound transcription factor peptidase/site-1 protease (MBTPS1/S1P), an SREBP control element, dramatically reduced infection by virulent hantaviruses of both the Old World and New World clades but not by rhabdoviruses or alphaviruses, indicating that this pathway is broadly, but selectively, required by hantaviruses. These results could be fully explained as arising from the modest depletion of cellular membrane cholesterol that accompanied S1P disruption. Mechanistic studies of cells and with protein-free liposomes suggested that high levels of cholesterol are specifically needed for hantavirus membrane fusion. Taken together, our results indicate that the profound dependence on target membrane cholesterol is a fundamental, and unusual, biophysical property of hantavirus glycoprotein-membrane interactions during entry. IMPORTANCE Although hantaviruses cause important human diseases worldwide, no specific antiviral treatments are available. One of the major obstacles to the development of new therapies is a lack of understanding of how hantaviruses hijack our own host factors to enter cells. Here, we identified multiple cellular genes that control the levels of cholesterol in cellular membranes to be important for hantavirus entry. Our findings suggest that high concentrations of cholesterol in cellular membranes are required at a specific step in the entry process-fusion between viral and cellular membranes-that allows escape of the hantavirus genome into the host cell cytoplasm to initiate infection. Our findings uncover a fundamental feature of the hantavirus infection mechanism and point to cholesterol-lowering drugs as a potential new treatment of hantaviral infections.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colesterol / Orthohantavirus / Internalización del Virus Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: MBio Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Colesterol / Orthohantavirus / Internalización del Virus Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: MBio Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos